Your browser doesn't support javascript.
loading
An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy response.
Dioken, Didem Naz; Ozgul, Ibrahim; Yilmazbilek, Irem; Yakicier, Mustafa Cengiz; Karaca, Ezgi; Erson-Bensan, Ayse Elif.
Affiliation
  • Dioken DN; Department of Biological Sciences, Middle East Technical University (METU), Dumlupinar Blv No:1 Universiteler Mah, Cankaya, 06800, Ankara, Türkiye.
  • Ozgul I; Department of Biological Sciences, Middle East Technical University (METU), Dumlupinar Blv No:1 Universiteler Mah, Cankaya, 06800, Ankara, Türkiye.
  • Yilmazbilek I; Department of Biological Sciences, Middle East Technical University (METU), Dumlupinar Blv No:1 Universiteler Mah, Cankaya, 06800, Ankara, Türkiye.
  • Yakicier MC; AQUARIUS/NPG Genetic Diseases Evaluation Center, Kucukbakkalkoy Mah. Kayisdagi Cad. 137/6 Atasehir, Istanbul, Türkiye.
  • Karaca E; Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, 35340, Balcova, Izmir, Türkiye.
  • Erson-Bensan AE; Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, 35340, Balcova, Izmir, Türkiye.
Cancer Immunol Immunother ; 72(12): 4065-4075, 2023 Dec.
Article in En | MEDLINE | ID: mdl-37768345
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans Language: En Year: 2023 Type: Article